01 8Gowling WLG (Canada) LLP
01 42906666
02 42946281
01 8BUPIVACAINE | MELOXICAM
01 8SOLUTION (EXTENDED RELEASE)
01 42034-03-13
02 42035-04-20
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Brand Name : ZYNRELEF
Patent Number : 2946281
Filing Date : 2015-04-20
Strength per Unit : 60 mg / 2.3 mL / 1.8 mg / 2.3 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Brand Name : ZYNRELEF
Patent Number : 2906666
Filing Date : 2014-03-13
Strength per Unit : 60 mg / 2.3 mL / 1.8 mg / 2.3 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Brand Name : ZYNRELEF
Patent Number : 2946281
Filing Date : 2015-04-20
Strength per Unit : 200 mg / 7 mL / 6 mg / 7 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Brand Name : ZYNRELEF
Patent Number : 2906666
Filing Date : 2014-03-13
Strength per Unit : 200 mg / 7 mL / 6 mg / 7 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Brand Name : ZYNRELEF
Patent Number : 2946281
Filing Date : 2015-04-20
Strength per Unit : 300 mg / 10.5 mL / 9 mg / 10.5 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Brand Name : ZYNRELEF
Patent Number : 2906666
Filing Date : 2014-03-13
Strength per Unit : 300 mg / 10.5 mL / 9 mg / 10.5 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Brand Name : ZYNRELEF
Patent Number : 2946281
Filing Date : 2015-04-20
Strength per Unit : 400 mg / 14 mL / 12 mg / 14 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Brand Name : ZYNRELEF
Patent Number : 2906666
Filing Date : 2014-03-13
Strength per Unit : 400 mg / 14 mL / 12 mg / 14 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
